Studies examining disease susceptibility in these CCR5-Δ32 homozygotes are ongoing and some studies have already been published on rheumatoid arthritis [41–43], systemic lupus erythematosis [41], inflammatory bowel disease [44], and multiple sclerosis [45,46] in these persons. This evidence concerns the gene CCR5 and multiple sclerosis.